Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
15,000
NCT06328075
Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis
Phase: N/A
Role: Collaborator
Start: Jan 1, 2022
Completion: Jan 1, 2026